Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
IPCALAB Stock Analysis
Views
Red Flags
Positive
Strong price momentum
Analysts have been raising forward EPS estimates
High and improving operating margin
Strong EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Company's earnings are of high quality
Consistently pays dividend
Company is net cash
Negative
Expensive and at a premium to industry median P/E
Low revenue growth and in line with median growth of industry
Low dividend yield
Neutral
Moderate and stable ROE
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
IPCALAB Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
IPCALAB Bulk, Block & Insider Trades
IPCALAB Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Stock split
Bonus(1 new shares for 1 existing shares)Issue of Bonus shares in the ratio of 1 fully paid equity share of Rs 10 each for every 1 equity share of Rs 10 each held in the Company subject to members approval. Ex-date: 28th Jan 2005 Announced on: 27th Oct 2004
Stock split(1 : 2)Nominal value change from INR 2.00 to 1.00 Ex-date: 10th Jan 2022 Announced on: 13th Nov 2021
Stock split(1 : 5)Nominal value changes from Rs 10 to Rs 2. Ex-date: 22nd Mar 2010 Announced on: 21st Jan 2010
Company Profile
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquin... Read More
Key personnel
Shri. Premchand GodhaD
Executive Chairman of the Board
Mr. Pranay Premchand GodhaD
Chief Executive Officer, Managing Director, Executive Director
Mr. Ajit Kumar JainD
Chief Financial Officer, Managing Director, Executive Director
Mr. Pabitra Kumar Bhattacharya
President - Operations (API)
Mr. Sunil Ghai
President - Marketing
Dr. Sanjay U. Kapadia
President - Corporate Quality Assurance
Dr. Ashok Kumar
President - Research and Development (Chemicals)
Mr. Shailesh Laul
President - Operations (Formulations)
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Ipca Laboratories Ltd.?
The current share price of Ipca Laboratories Ltd. is ₹ 1,572.28 as of 09 Jan 2026.
What is the PE ratio of Ipca Laboratories Ltd.?
The Price-to-Earnings (PE) ratio of Ipca Laboratories Ltd. is 47.96 as of the latest financial data.
What is the ROE and ROCE of Ipca Laboratories Ltd.?
Ipca Laboratories Ltd. has a Return on Equity (ROE) of 11.77% and a Return on Capital Employed (ROCE) of 14.91% as per the latest financial reports.
What is the market cap of Ipca Laboratories Ltd.?
The market capitalization of Ipca Laboratories Ltd. stands at ₹ 39,889.40 Cr.
What is the dividend yield of Ipca Laboratories Ltd.?
The dividend yield of Ipca Laboratories Ltd. is 0.25% based on the current market price.
What is the RSI of Ipca Laboratories Ltd.?
The Relative Strength Index (RSI) of Ipca Laboratories Ltd. is 70.71.
What is the FII and DII holding in Ipca Laboratories Ltd.?
Foreign Institutional Investors (FII) hold 10.42% and Domestic Institutional Investors (DII) hold 36.03% of Ipca Laboratories Ltd. shares.
What sector does Ipca Laboratories Ltd. belong to?
Ipca Laboratories Ltd. operates in the Healthcare sector.
What is the beta of Ipca Laboratories Ltd. stock?
The beta of Ipca Laboratories Ltd. stock is 0.79, indicating its volatility relative to the broader market.
